State Of Wisconsin Investment Board Vaxart, Inc. Transaction History

State Of Wisconsin Investment Board

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.09 - $4.5 $14,168 - $30,505	-6,779 Reduced 5.05%	127,370 $278,000
Q2 2022 Aug 15, 2022	SELL	$2.7 - $5.28 $54,947 - $107,453	-20,351 Reduced 13.17%	134,149 $470,000
Q1 2022 May 13, 2022	SELL	$4.29 - $6.64 $213,213 - $330,008	-49,700 Reduced 24.34%	154,500 $779,000
Q4 2021 Feb 11, 2022	BUY	$5.77 - $7.96 $51,352 - $70,844	8,900 Added 4.56%	204,200 $1.28 Million
Q3 2021 Nov 12, 2021	BUY	$6.67 - $9.8 $272,136 - $399,840	40,800 Added 26.41%	195,300 $1.55 Million
Q2 2021 Aug 12, 2021	BUY	$5.06 - $10.78 $424,533 - $904,442	83,900 Added 118.84%	154,500 $1.16 Million
Q1 2021 May 17, 2021	SELL	$5.64 - $23.33 $18,048 - $74,656	-3,200 Reduced 4.34%	70,600 $427,000
Q4 2020 Feb 03, 2021	BUY	$3.5 - $7.98 $258,300 - $588,924	73,800 New	73,800 $421,000

108

37.9M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $93.6M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.